| Name | Title | Contact Details |
|---|
The mission of Life Line Screening is to make people aware of an undetected health problem and encourage them to seek follow up care with their physician. We are dedicated to providing the highest quality preventive screenings at an affordable rate.
Wimbledon Health Partners formed in 2013 to meet the need for on-site diagnostic testing at physicians’ offices. The industry leader, Wimbledon Health Partners provides physicians with state-of-the-art, in-office testing to detect circulatory conditions using vascular ultrasound and electro- and echocardiography. Nerve conduction velocity testing is also used to support diagnosis of problems related to the nervous and muscular systems. Wimbledon Athletics, the newest division of Wimbledon Health Partners, is pioneering the way for high schools, colleges and universities to test students for unsuspected heart abnormalities to help minimize sudden cardiac death among young athletes.
Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.
MIDWEST OPTICAL SYSTEMS is a Palatine, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Amrus Enterprises is a Fords, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.